Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UTMD financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. UTMD recently traded at $64.17. Market cap is $203.78M. P/E ratio is 19.03. Revenue is $37.53M.
| Metric | Value |
|---|---|
| Price | $64.17 |
| Market Cap | $203.78M |
| P/E Ratio | 19.03 |
| EPS | $3.38 |
| Dividend Yield | 0.31% |
| 52-Week High | $71.81 |
| 52-Week Low | $51.26 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $37.53M |
| Net Income | $10.85M |
| Gross Margin | 57.94% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $38.52M | $11.29M | $3.48 |
| 2024 | $40.90M | $13.87M | $3.96 |
| 2023 | $50.22M | $16.64M | $4.58 |
| 2022 | $52.28M | $16.47M | $4.53 |
UTMD analyst coverage data. Average price target: $0.00.